1. Wells and Geneva decision rules to predict pulmonary embolism: can we use them in Covid-19 patients?
- Author
-
J. F. Pinto, Beatriz Silva, S Pereira, P Alves Da Silva, P Morais, Joana Rigueira, G. A. Almeida, Cláudia Jorge, Rui Plácido, P Silverio Antonio, J Brito, T Rodrigues, and Repositório da Universidade de Lisboa
- Subjects
medicine.medical_specialty ,Receiver operating characteristic ,business.industry ,Incidence (epidemiology) ,Area under the curve ,Retrospective cohort study ,General Medicine ,medicine.disease ,Pulmonary embolism ,Extracardiac Findings ,Embolism ,Internal medicine ,Pulmonary angiography ,Medicine ,Radiology, Nuclear Medicine and imaging ,AcademicSubjects/MED00200 ,Cardiology and Cardiovascular Medicine ,business ,Geneva score - Abstract
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2021. For permissions please email: Journals.permissions@oup.com. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model), Pulmonary embolism (PE) is a recognized complication of SARS-COV2 infection due to hypercoagulability. Before the COVID era, the need for computed tomography pulmonary angiography (CTPA) to rule out PE was determined by clinical probability, based on Wells and Geneva scores, in association with D-dimer measurements. However, patients with SARS-COV2 infection have a pro-thrombotic and pro-inflammatory state which may compromise the usefulness of these algorithms to select patients for CTPA.
- Published
- 2021